Literature DB >> 20555094

Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines.

D E Peterson1, R-J Bensadoun, F Roila.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20555094     DOI： 10.1093/annonc/mdq197

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  13 in total

1.  The MASCC/ISOO mucositis guidelines: dissemination and clinical impact.

Authors:  Rajesh V Lalla; Fredrick D Ashbury
Journal:  Support Care Cancer       Date:  2013-08-14       Impact factor: 3.603

2.  Digestive toxicities after palliative three-dimensional conformal radiation therapy (3D-CRT) for cervico-thoracic spinal metastases.

Authors:  Guillaume Peyraga; Delphine Caron; Thibaut Lizee; Yann Metayer; Anne-Lise Septans; Yoann Pointreau; Fabrice Denis; Gerard Ganem; Cedrik Lafond; Sophie Roche; Olivier Dupuis
Journal:  Support Care Cancer       Date:  2017-12-23       Impact factor: 3.603

3.  Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab.

Authors:  Naoya Murakami; Seiichi Yoshimoto; Fumihiko Matsumoto; Takao Ueno; Yoshinori Ito; Satoru Watanabe; Kazuma Kobayashi; Ken Harada; Mayuka Kitaguchi; Shuhei Sekii; Kana Takahashi; Kotaro Yoshio; Koji Inaba; Madoka Morota; Minako Sumi; Yutaka Saito; Jun Itami
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-15       Impact factor: 4.553

Review 4.  Supportive care treatment guidelines: value, limitations, and opportunities.

Authors:  Douglas E Peterson; Rene-Jean Bensadoun; Rajesh V Lalla; Deborah B McGuire
Journal:  Semin Oncol       Date:  2011-06       Impact factor: 4.929

5.  Radiation damage and radioprotectants: new concepts in the era of molecular medicine.

Authors:  M I Koukourakis
Journal:  Br J Radiol       Date:  2012-01-31       Impact factor: 3.039

6.  SAMITAL® improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: results of a randomized, placebo-controlled, single-blind Phase II study.

Authors:  D Pawar; R S Neve; S Kalgane; A Riva; E Bombardelli; M Ronchi; G Petrangolini; P Morazzoni
Journal:  Support Care Cancer       Date:  2012-09-04       Impact factor: 3.603

7.  Protein fraction of Calotropis procera latex protects against 5-fluorouracil-induced oral mucositis associated with downregulation of pivotal pro-inflammatory mediators.

Authors:  Ana Paula F Freitas; Flavio S Bitencourt; Gerly Anne C Brito; Nylane Maria N de Alencar; Ronaldo A Ribeiro; Roberto Cesar P Lima-Júnior; Marcio V Ramos; Mariana L Vale
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-14       Impact factor: 3.000

Review 8.  Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis.

Authors:  C E Dandoy; M I Ardura; G A Papanicolaou; J J Auletta
Journal:  Bone Marrow Transplant       Date:  2017-03-27       Impact factor: 5.174

Review 9.  MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Authors:  Rajesh V Lalla; Joanne Bowen; Andrei Barasch; Linda Elting; Joel Epstein; Dorothy M Keefe; Deborah B McGuire; Cesar Migliorati; Ourania Nicolatou-Galitis; Douglas E Peterson; Judith E Raber-Durlacher; Stephen T Sonis; Sharon Elad
Journal:  Cancer       Date:  2014-02-25       Impact factor: 6.860

Review 10.  Prevention and management of mucositis in patients with cancer: a review article.

Authors:  Fatemeh Owlia; Seid Kazem Kazemeini; Neda Gholami
Journal:  Iran J Cancer Prev       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.